iTransfuse 对比 ARF RHD Guidelines 的使用情况和统计数据

The iTransfuse App promotes safe, appropriate and evidence-based transfusion by providing bedside access to transfusion education tools and resources. It includes information to support the prescription of red cells and platelets, diagnostic information about transfusion reactions, and much more.
  • Apple 应用商店
  • 免费
  • 医疗

商店排名

- -

Rheumatic heart disease represents the greatest cardiovascular inequality between Indigenous and non-Indigenous Australians. From 2013 to 2017, 94% of all new rheumatic heart disease cases were among Aboriginal and Torres Strait Islander people. This app assists clinicians in the diagnosis and management of acute rheumatic fever and rheumatic heart disease. Published by RHDAustralia, based at Menzies School of Health Research, the app contains the most up-to-date evidence and details various aspects of patient care. It is informed by the 2020 Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease (3rd edition), available at https://www.rhdaustralia.org.au/arf-rhd-guideline. The app also contains an ARF Diagnosis Calculator which embeds the lengthy and complex ARF diagnosis algorithms into a series of simple questions that assist clinicians to diagnose ARF. The algorithms comply with the 2015 American Heart Association revision of the Jones Criteria for diagnosis of ARF, which has been endorsed by the World Heart Federation, making the Diagnosis Calculator now able to be used globally.
  • Apple 应用商店
  • 免费
  • 医疗

商店排名

- -

iTransfuse与ARF RHD Guidelines排名比较

对比 iTransfuse 与 ARF RHD Guidelines 在过去 28 天内的排名趋势

排名

没有可用的数据

iTransfuse 对比 ARF RHD Guidelines 的排名,按国家/地区比较

对比 iTransfuse 与 ARF RHD Guidelines 在过去 28 天内的排名趋势

无数据可显示

通过免费试用版比较任何网站

开始使用
iTransfuse VS.
ARF RHD Guidelines

十二月 14, 2024